JPH0531524B2 - - Google Patents

Info

Publication number
JPH0531524B2
JPH0531524B2 JP59175325A JP17532584A JPH0531524B2 JP H0531524 B2 JPH0531524 B2 JP H0531524B2 JP 59175325 A JP59175325 A JP 59175325A JP 17532584 A JP17532584 A JP 17532584A JP H0531524 B2 JPH0531524 B2 JP H0531524B2
Authority
JP
Japan
Prior art keywords
same
salts
administered
stable
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59175325A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6072815A (ja
Inventor
Ruiji Asupeshii Pieeru
Gennari Fuederiko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioresearch SRL
Original Assignee
Bioresearch SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch SRL filed Critical Bioresearch SRL
Publication of JPS6072815A publication Critical patent/JPS6072815A/ja
Publication of JPH0531524B2 publication Critical patent/JPH0531524B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
JP59175325A 1983-08-24 1984-08-24 安定なｓ−アデノシル−ｌ−メチオニン塩を含有する経口使用のための治療用組成物 Granted JPS6072815A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22621-A/83 1983-08-24
IT22621/83A IT1169772B (it) 1983-08-24 1983-08-24 Composizioni terapeutiche per uso orale contenenti sali stabili della s-adenosil-l-metionina

Publications (2)

Publication Number Publication Date
JPS6072815A JPS6072815A (ja) 1985-04-24
JPH0531524B2 true JPH0531524B2 (en, 2012) 1993-05-12

Family

ID=11198524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59175325A Granted JPS6072815A (ja) 1983-08-24 1984-08-24 安定なｓ−アデノシル−ｌ−メチオニン塩を含有する経口使用のための治療用組成物

Country Status (7)

Country Link
EP (1) EP0136464B1 (en, 2012)
JP (1) JPS6072815A (en, 2012)
AT (1) ATE38151T1 (en, 2012)
AU (1) AU563762B2 (en, 2012)
CA (1) CA1224418A (en, 2012)
DE (1) DE3474774D1 (en, 2012)
IT (1) IT1169772B (en, 2012)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3678643D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Partikel mit konstanter wirkstofffreisetzung.
DE3678644D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
DE3678641D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Partikel mit konstanter wirkstofffreisetzung.
WO1988002629A1 (en) * 1986-10-16 1988-04-21 American Health Products Corporation 2',3'-didesoxyadenosine composition
GB8900812D0 (en) * 1989-01-14 1989-03-08 Univ Manchester Pharmaceutical method and compositions
IT1229479B (it) * 1989-03-13 1991-09-03 Bioresearch Spa Impiego di 5' deossi 5' metiltioadenosina, di s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a favorire la crescita dei capelli in soggetti affetti da calvizie e composizioni farmaceutiche relative.
US6759395B2 (en) 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
WO2002049637A1 (en) * 2000-12-18 2002-06-27 Orchid Chemicals And Pharmaceuticals Limited A novel soft-gelatin capsule comprising s-adenosylmethionine and a method for producing the same
EP1325740B1 (en) 2001-12-12 2004-04-21 Chemistry & Health International B.V. Stable granulates containing S-Adenosylmethionine and process for the preparation thereof
CN101677543A (zh) * 2007-01-31 2010-03-24 甲基化物科学国际有限公司 S-腺苷甲硫氨酸的延时释放药物制剂
EP2193787A1 (en) 2008-12-02 2010-06-09 Giorgio Stramentinoli Formulations for systemic buccal delivery comprising s-adenosylmethionine, their preparation and use
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EA201100309A1 (ru) * 2011-03-03 2011-08-30 Екофарм Патент Менеджмент Аг Фармацевтическая композиция, стимулирующая биосинтез s-аденозилметионина, и пероральное лекарственное средство
KR20160094451A (ko) 2012-10-17 2016-08-09 메틸레이션 사이언시즈 인터내셔널 에스알엘 S-아데노실메티오닌 및 갈산 에스테르가 포함된 조성물
WO2024238657A2 (en) 2023-05-15 2024-11-21 Bonafide Health, Llc Sleep-improving compositions and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
JPS5347536A (en) * 1976-10-12 1978-04-28 Abbott Lab Pharmaceutical composition for treatment of fertile skin disease
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
IT1137892B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.PHARMACOL.EXP.THER=1979 *

Also Published As

Publication number Publication date
ATE38151T1 (de) 1988-11-15
IT1169772B (it) 1987-06-03
JPS6072815A (ja) 1985-04-24
EP0136464A2 (en) 1985-04-10
IT8322621A0 (it) 1983-08-24
CA1224418A (en) 1987-07-21
AU563762B2 (en) 1987-07-23
DE3474774D1 (en) 1988-12-01
AU3232684A (en) 1985-02-28
EP0136464B1 (en) 1988-10-26
EP0136464A3 (en) 1985-07-03

Similar Documents

Publication Publication Date Title
JPH0531524B2 (en, 2012)
US5332727A (en) Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
George et al. Metabolism of isoprenaline in the intestine
Rosenthal et al. Thyrotoxic vomiting.
Yeung et al. Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm
UA63032C2 (en) Drug for treating hypertension
JP3852621B2 (ja) 血管内皮細胞機能改善剤
JPH09501163A (ja) 神経学的損傷からの保護のための薬物
Mathias et al. Migrating action potential complex of cholera: a possible prostaglandin-induced response.
Hallgren et al. Effects of nitric oxide inhibition on duodenal function in rat: involvement of neural mechanisms
TH et al. Clinical investigations of fluothane.
Myren et al. The early effect of trimipramine (Surmontil) on gastric secretion in man
US4778785A (en) Pharmaceutical composition for retarding and reducing cachexia
JPH02134321A (ja) 変形関節炎治療用薬剤を製造するための６―ハロ―４―キノロン化合物およびそれらの薬学的組成物の使用
Lavigne et al. Inhibition of the gastrointestinal absorption of p‐aminosalicylate (PAS) in rats and humans by diphenhydramine
JPS6031810B2 (ja) 静細胞的に活性なアルキル化剤の解毒
Loukanov et al. Animal models related to congenital heart disease and clinical research in pulmonary hypertension
JP3717189B2 (ja) 鎮痛抗炎症剤
RU2045961C1 (ru) Способ проведения коронарографии в эксперименте
JPH01221316A (ja) 脳循環代謝改善剤
JPH04211013A (ja) スティグマスタ−４−エン−３−オンを含む薬剤およびその用途
RU2211035C1 (ru) Противотуберкулезный препарат
JPH0326167B2 (en, 2012)
JPS6045161B2 (ja) 熱傷の治療剤
KR100198490B1 (ko) 간장질환 치료용 의약 조성물